| Stage | BX | % of rev | AAMI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $5.0B | 100.00% | $185M | 100.00% | BX ×27.25 |
| Gross profit | $5.0B | 100.00% | $64M | 34.52% | BX +65.5pp |
| Operating income | $2.7B | 52.90% | $32M | 17.50% | BX +35.4pp |
| Pre-tax income | $2.8B | 55.68% | $39M | 20.96% | BX +34.7pp |
| Net income | $2.4B | 46.71% | $29M | 15.88% | BX +30.8pp |
| Stage | BX | AAMI | Gap · A − B |
|---|---|---|---|
| Revenue | $5.0B100.00% | $185M100.00% | BX ×27.25 |
| Gross profit | 100.00%$5.0B | 34.52%$64M | BX +65.5pp |
| Operating income | 52.90%$2.7B | 17.50%$32M | BX +35.4pp |
| Pre-tax income | 55.68%$2.8B | 20.96%$39M | BX +34.7pp |
| Net income |
| 46.71%$2.4B |
| 15.88%$29M |
| BX +30.8pp |
No shared counterparties.